El-Atawneh, S., & Goldblum, A. (2022, February). Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors. Frontiers in Pharmacology.
Chicago Style (17th ed.) CitationEl-Atawneh, Shayma, and Amiram Goldblum. "Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors." Frontiers in Pharmacology Feb. 2022.
MLA (9th ed.) CitationEl-Atawneh, Shayma, and Amiram Goldblum. "Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors." Frontiers in Pharmacology, Feb. 2022.
Warning: These citations may not always be 100% accurate.